Arrakis Therapeutics
Arrakis Therapeutics

Arrakis Therapeutics

Measured by AhrefsDR30Ahrefs DR: 30/100. Below median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent47Agent Readiness: 47/100. Above median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed68Site Speed: 68/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust62Data Trust: 62/100. Above median. Measured by StartupHub.ai. Median 61.

Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. The company is based in Waltham, Mas

Website
2014Active52Waltham, United States

About

Arrakis Therapeutics is pioneering a new class of genetic medicines called RNA-targeted small molecules (rSMs) to unlock new biology and create oral medicines. Their robust technology platform and toolkit enable the industrialization of rSM discovery, with a growing pipeline of programs aimed at treating patients. Arrakis is currently advancing an rSM drug candidate to address the root cause of Myotonic Dystrophy Type 1 (DM1).

Competitors & Alternatives (8)

Also in this space

DG
Deep Genomics
Deep Genomics

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Shares Biotech, Drug Discovery

AB
Avidity Biosciences
Avidity Biosciences

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Shares Biotech, Drug Discovery

NT
NRG Therapeutics
NRG Therapeutics

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

Shares Biotech, Drug Discovery

DT
Denali Therapeutics
Denali Therapeutics

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Shares Biotech, HealthTech

C
Cradle
Cradle

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Shares Biotech, HealthTech

AB
Adaptive Biotechnologies
Adaptive Biotechnologies

Leveraging the adaptive immune system to diagnose and treat disease.

Shares Biotech, HealthTech

Key facts

Website
arrakistx.com
Headquarters
Waltham, United States
Founded
2014
Employees
52
Business model
B2B

Tech stack

Detected on arrakistx.com, last scanned 6 Sept 2026.

Frontend
jQuery
Analytics
Google Analytics 4
SEO
Yoast SEO
CMS / Builders
WordPress
CDN
Cloudflare
Run your own scan

Arrakis Therapeutics scores 30. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Comments
(3)

3 reviews from Reddit gathered in one place

Reddit
r/biotechu/Veritaz27Apr 28, 2026NegativeReddit

Arrakis Therapeutics Layoff <MA>. Word on the street is Arrakis Therapeutics just recently announced layoff in order to consolidate resources around their lead asset.

Reddit
r/biotechu/H2AK119ubMar 3, 2024NegativeReddit

Arrakis Therapeutics reduces headcount by 20%.

Reddit
r/chpresseschauu/transpostmetaApr 8, 2020PositiveReddit

Pharmaunternehmen - Roche schliesst Lizenzvereinbarung mit Arrakis Therapeutics, Der Pharmakonzern Roche hat sich auf eine Lizenzvereinbarung mit dem US-Biotechunternehmen Arrakis Therapeutics geeinigt..

Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.

Frequently asked

Is Arrakis Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Arrakis Therapeutics is 62 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How many employees does Arrakis Therapeutics have?

Arrakis Therapeutics has approximately 52 people on record.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Arrakis Therapeutics